Delivery Order SPE2DB22D1103-SPE2DB24FTBC6
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Dupixent 300 mg/2 ml syringes. The $6,422.04 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of February 3, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Dupixent 300 mg/2 ml syringe (2 ml) to the Defense Logistics Agency (DLA) Troop Support Medical. The $25,934.80 firm-fixed-price delivery order has an ultimate completion date of October 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The award, with a Ceiling Value of $11,108.88, is for the delivery of Dupixent 300 mg/2 ml syringes. This delivery order is part of the company's comprehensive IDC to provide a wide range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Dupixent 200 mg/1.14 ml syringes. The $52,992.43 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of February 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,389.04 firm fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml syringe and has an ultimate completion date of January 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award to Amerisourcebergen Drug Corp, a division of parent company Cencora, Inc., is a Delivery Order valued at $49,738.83 for the supply of Dupixent 300 mg/2 ml syringes. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,435.39 firm fixed-price contract is for the supply of Dupixent 300 mg/2 ml syringes and has an ultimate completion date of January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $26,542.08 for the supply of Dupixent 200 mg/1.14 ml syringes. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,917.67 for the pharmaceutical product Dupixent 300 mg/2 ml syringe. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 30, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $26,954.16 firm fixed-price contract is for the supply of Dupixent 300 mg/2 ml syringes, with a performance period ending on May 6, 2022. Amerisourcebergen, a major pharmaceutical distributor, has a significant $999,999,999 IDC with the DLA Troop Support Medical that runs...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTBC6Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml syringe, 2 ml, with a ceiling value of $19,647.96 and a performance period through November 7, 2023. The contract is a firm-fixed-price type, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 IDC with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of Amerisourcebergen's broader contract portfolio with the DLA and other federal agencies, demonstrating its role as a critical supplier of essential medical commodities to the U.S. government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.6k | 11/6/23 |